On-line haemodiafiltration: State of the art

Nephrology Dialysis Transplantation

Volumn 13, Issue SUPPL. 5, 1998, Pages 3-11

  Canaud, B ^a   Bosc, J Y ^a   Leray, H ^a   Stec, F ^a   Argiles, A ^a   Leblanc, M ^a   Mion, C ^a  

^a LAPEYRONIE HOSPITAL   (France)

Author keywords

Dialysis; End stage renal failure; On line haemodiafiltration; Renal replacement therapy

Indexed keywords

BETA 2 MICROGLOBULIN; BICARBONATE; BUFFER; UREA; UREMIC TOXIN;

ACIDOSIS; AUTOMATION; CARDIOVASCULAR DISEASE; CONFERENCE PAPER; DIALYSATE; FEEDBACK SYSTEM; HEMODIALYSIS; HEMODYNAMICS; HEMOFILTRATION; HIGH RISK PATIENT; HUMAN; KIDNEY FAILURE; MEMBRANE; MOLECULAR WEIGHT; PRIORITY JOURNAL; SAFETY;

EID: 0031967747     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: 10.1093/ndt/13.suppl_5.3     Document Type: Conference Paper

References (55)

1. Henderson LW, Besarab A, Michaels A, Bluemle LW. Blood purification by ultrafiltration and fluid replacement (diafiltration). Trans Am Soc Artif Intern Organs 1967; 13: 216-222.
2. Leber HW, Wizemann V, Goubeaud G, Rawer P, Schütterle G. Hemodiafiltration: a new alternative to hemofiltration and conventional hemodialysis. Artif Organs 1978; 2: 150-153.
3. Shinzato T, Sezaki R, Usuda M, Maeda K, Ohbayashi S, Toyota T. Infusion-free hemodiafiltration: simultaneous hemofiltration and dialysis with no need for infusion fluid. Artif Organs 1982; 6: 453-456.
4. Sprenger KBG. Haemodiafiltration. Life Support System 1983; 1: 127-136.
5. Henderson LW, Sanfelippo ML, Beans E. 'On-line' preparation of sterile pyrogen-free electrolyte solution. Trans Am Soc Artif Intern Organs 1978; 24: 465-467.
6. Maeda K, Shinzato T. Push/pull hemodiafiltration: technical aspects and clinical effectiveness. Nephron 1995; 71: 1-9.
7. Canaud B, Peyronnet P, Armynot AM et al. Ultrapure water: a need for future dialysis. Nephrol Dial Transplant 1986; 1: 110.
8. Canaud BJM, Mion CM. Water treatment for contemporary hemodialysis. In: Jacobs C, Kjellstrand CM, Koch KM, Winchester JF, eds. Replacement of Renal Function by Dialysis. Kluwer Academic Publishers, Dordrecht: 1996: 231-255.
9. Schindler R, Lonnemann G, Schaffer J, Shaldon S, Koch KM, Krautzig S. The effect of ultrafiltered dialysate on the cellular content of interleukin-1 receptor antagonist in patients on chronic hemodialysis. Nephron 1994; 68: 229-233.
10. Mion CM, Canaud B. Should hemodialysis fluid be sterile? Semin Dial 1993; 6: 28-30.
11. Mion CM, Canaud B. 'On-site' preparation of sterile apyrogenic electrolyte solutions for hemofiltration and hemodiafiltration. In: Cambi V, ed. Short Dialysis. Martinus Nijhoff Publishing, Boston: 1987: 261-291.
12. Sundaram S, Barrett TW, Meyer KB et al. Transmembrane passage of cytokine-inducing bacterial products across new and reprocessed polysulfone dialyzers. J Am Soc Nephrol 1996; 7: 2183-2191.
13. Bommer J, Becker KP, Urbaschek R. Potential transfer of endotoxin across high-flux polysulfone membranes. J Am Soc Nephrol 1996; 7: 883-888.
14. Capelli G, Tetta C, Cornia F et al. Removal of limulus reactivity and cytokine-inducing capacity from bicarbonate dialysis fluids by ultrafiltration. Nephrol Dial Transplant 1993; 8: 1133-1139.
15. Ward RA, Luehmann DA, Klein E. Are current standards for the microbiological purity of hemodialysate adequate? Semin Dial 1989; 2: 69-72.
16. Pass T, Wright R, Sharp B, Harding GB. Culture of dialysis fluids on nutrient-rich media for short periods at elevated temperatures underestimate microbial contamination. Blood Purif 1996; 14: 136-145.
17. Krautzig S, Linnenweber S, Schindler R, Shaldon S, Koch KM, Lonnemann G. New indicators to evaluate bacteriological quality of the dialysis fluid and the associated inflammatory response in ESRD patients. Nephrol Dial Transplant 1996; 11 [Suppl 2]: S87-S91.
18. Garred LJ, Barichello DL, Canaud B, McCready W. Simple equations for protein catabolic rate determinations from pre dialysis and post dialysis blood urea nitrogen. Am Soc Artif Intern Organs 1995; 41: 889-895.
19. Hakim RM, Breyer J, Ismail N, Schulman G. Effects of dose of dialysis on morbidity and mortality. Am J Kidney Dis 1994; 23: 661-669.
20. Parker TF, Husni L, Huang W, Lew N, Lowrie EG, Dallas Nephrology Associates. Survival of hemodialysis patients in the United States is improved with a greater quantity of dialysis. Am J Kidney Dis 1994; 23: 670-680.
21. Port F. Morbidity and mortality in dialysis patients. Kidney Int 1994; 46: 1728-1737.
22. Ballardie FW, Kerr DNS, Tennent G, Pepys MB. Haemodialysis versus CAPD: equal predisposition to amyloidosis? Lancet 1986; I: 795-796.
23. Ringoir S, Schoots A, Vanholder R. Uremic toxins. Kidney Int 1988; 33 [Suppl 24]: S4-S9.
24. Canaud B, Assounga A, Flavier JL et al. β2-Microglobulin serum levels in maintenance dialysis. Trans Am Soc Artif Intern Organs 1988; 34: 923-929.
25. Floege J, Granolleras C, Deschodt G et al. High-flux synthetic versus cellulosic membranes for beta2-microglobulin during hemodialysis, hemodiafiltration and hemofiltration. Nephrol Dial Transplant 1989; 4: 653-657.
26. Kerr PB, Argiles A, Flavier JL, Canaud B, Mion CM. Comparison of hemodialysis and hemodiafiltration: a long-term longitudinal study. Kidney Int 1992; 41: 1035-1040.
27. Vlassara H. Serum advanced glycosylation end products: a new class of uremic toxins? Blood Purif 1994; 12: 54-59.
28. Ritz E, Deppisch R, Nawroth P. Toxicity of uraemia - does it come of AGE? Nephrol Dial Transplant 1994; 9: 1-2.
29. Witko-Sarsat V, Friedlander M, Capeillère-Blandin C et al. Advanced oxidation protein products as a novel marker of oxidative stress in uremia. Kidney Int 1996; 49: 1304-1313.
30. Kult J, Stan DE, Matata BM, Mahiout A. Improved elimination of low-molecular weight proteins with a new polysulfone membrane superflux during hemodialysis. J Am Soc Neprol ( Abstract) 1996; 7: 1410-1411.
31. Gonella M, Calabrese G, Pratesi G, Baldin C, Mazzotta A, Vagelli G. New reinfusate composition in high UF haemodiafiltration: electrolyte solution combined with bicarbonate. Nephrol Dial Transplant 1993; 8: 54-59.
32. Wizemann V, Kramer W, Knopp G, Mueller K, Schütterle G. Ultrashort hemodiafiltration: efficiency and hemodynamic tolerance. Clin Nephrol 1983; 19: 24-30.
33. Takenaka T, Tsuchiya Y, Suzuki H. High-performance hemodiafiltration and blood pressure stability. Nephron 1997; 75: 30-35.
34. Baldamus CA, Ernst W, Frei U, Koch KM. Sympathetic and hemodynamic response to volume removal during different forms of renal replacement therapy. Nephron 1982; 31: 324-332.
35. van Kuijk WH, Wirtz JJ, Grave W et al. Vascular reactivity during combined ultrafiltration-haemodialysis: influence of dialysate sodium. Nephrol Dial Transplant 1996; 11: 323-328.
36. Arese M, Cristol JP, Bosc JY et al. Removal of constitutive and inducible nitric oxide synthase-active compounds in a modified hemodiafiltration with on-line production of substitution fluid: the contribution of convection and diffusion. Int J Artif Organs 1996; 19: 704-711.
37. Baz M, Durand C, Ragon A et al. Using ultrapure water in hemodialysis delays carpal tunnel syndrome. Int J Artif Organs 1991; 14: 681-685.
38. van Ypersele de Strihou C, Jadoul M, Malghem J, Maldague B, Jamart J. Effect of dialysis membrane and patient's age on signs of dialysis-related amyloidosis. Kidney Int 1991; 39: 1012-1019.
39. Birk HW, Kister A, Wizemann V, Schütterle G. Protein adsorption by artificial membrane materials under filtration conditions. Artif Organs 1995; 19: 411-415.
40. Teruel JL, Pascual J, Serrano P, Ortuno J. ACE inhibitors and AN69 membranes: absence of anaphylactoid reactions in haemodiafiltration process. Nephrol Dial Transplant 1992; 7: 275.
41. Klinkmann H, Ebbighausen H, Uhlenbusch I. High-flux dialysis, dialysate quality and backtransport. Contrib Nephrol 1993; 103: 89-97.
42. Ofsthun NJ, Leypoldt JK. Ultrafiltration and backflltration during hemodialysis. Artif Organs 1995; 19: 1143-1161.
43. Schmidt M, Baldamus CA, Schoeppe W. Backfiltration in hemodialyzers with highly permeable membranes. Blood Purif 1984; 2: 108-114.
44. Sternby J. A decade of experience with on-line hemofiltration/ hemodiafiltration. Contrib Nephrol 1994; 108: 1-11.
45. Lonnemann G, Behme TC, Lenzner B et al. Permeability of dialyzer membranes to TNFα-inducing substances derived from water bacteria. Kidney Int 1992; 42: 61-68.
46. Evans RC, Holmes CJ. In vitro study of the transfer of cytokine inducing substances across selected high flux hemodialysis membranes. Blood Purif 1991; 9: 92-101.
47. Ramperez P, Beau MC, Deschodt G, Flavier JL, Nielsson L, Mion C. Economic preparation of sterile pyrogen-free infusate for hemofiltration. Proc Eur Dial Transplant Assoc 1981; 18: 293-296.
48. Canaud B, Imbert E, Kaaki M et al. Clinical and microbiological evaluation of a postdilutional hemofiltration system with in-line production of substitution fluid. Blood Purif 1990; 8: 160-170.
49. Canaud B, Nguyen QV, Argilés A, Polito C, Polaschegg HD, Mion C. Hemodiafiltration using dialysate as substitution fluid. Artif Organs 1987; 11: 188-190.
50. Canaud B, Nguyen QV, Polito C, Stec F, Mion C. Hemodiafiltration with on-line production of bicarbonate infusate. Contrib Nephrol 1989; 74: 91-100.
51. Canaud B, Flavier JL, Argilés A et al. Hemodiafiltration with on-line production of substitution fluid: long-term safety and quantitative assessment of efficacy. Contrib Nephrol 1994; 108: 12-22.
52. Gordon SM, Oettinger CW, Bland LA et al. Pyrogenic reactions in patients receiving conventional, high-efficiency, or high-flux hemodialysis treatments with bicarbonate dialysate containing high concentrations of bacteria and endotoxin. J Am Soc Nephrol 1992; 2: 1436-1444.
53. Golper TA. What technological advances will significantly alter the future care of dialysis patients? Semin Dial 1994; 7: 323-324.
54. Canaud B, Kerr P, Argilés A, Flavier JL, Stec F, Mion C. Is hemodiafiltration the dialysis modality of choice for the next decade? Kidney Int 1993; 43 [Suppl 41]: S296-S299.
55. Henderson LW. Dialysis in the 21st century. Am J Kidney Dis 1996; 28: 951-957.